Ohara N, Ono H, Hashimoto K
Jpn Circ J. 1981 Jun;45(6):672-9. doi: 10.1253/jcj.45.672.
Acute effects of captopril (SQ 14 225) on blood pressure were investigated in pentobarbital anesthetized dogs. Intravenous captopril (0.1-3 mg/kg) caused reduction of blood pressure dose-independently, while dose-dependent attenuation of exogenous angiotensin I-induced pressor response and potentiation of bradykinin-induced reduction of blood pressure were observed wih the same doses of this agent. This acute decrease in blood pressure was partially inhibited by a pretreatment with any one of aprotinin, Sar1-Ile-8-angiotensin II and indomethacin. More significant inhibition of the blood pressure decrease was observed after the combined pretreatment with Sar1-Ile8-angiotensin II and indomethacin or that with all the three drugs, though no complete abolition of the blood pressure decrease was achieved. These results suggest that captopril may decrease blood pressure in anesthetized dogs through other mechanism(s) in addition to angiotensin converting enzyme inhibition, including the prostaglandin release probably from the kidney.
在戊巴比妥麻醉的犬中研究了卡托普利(SQ 14 225)对血压的急性作用。静脉注射卡托普利(0.1 - 3mg/kg)可非剂量依赖性地降低血压,而相同剂量的该药物可观察到对外源性血管紧张素I诱导的升压反应的剂量依赖性减弱以及对缓激肽诱导的血压降低的增强作用。用抑肽酶、Sar1 - Ile - 8 - 血管紧张素II和吲哚美辛中的任何一种进行预处理可部分抑制这种急性血压降低。在用Sar1 - Ile8 - 血管紧张素II和吲哚美辛联合预处理或用这三种药物联合预处理后,观察到对血压降低的抑制作用更显著,尽管未完全消除血压降低。这些结果表明,卡托普利除了抑制血管紧张素转换酶外,可能还通过其他机制降低麻醉犬的血压,包括可能从肾脏释放的前列腺素。